KO
Coca Cola Femsa Q1 Earnings Call Highlights
Coca Cola Femsa (NYSE:KOF) reported first-quarter 2026 volume growth of 1.2% to 998 million unit cases, as strength across most territories offset a decline in Mexico amid an excise tax increase and softer consumer conditions. Total revenues rose 1.1% to MXN 70.9 billion, while gross profit increase
MarketBeat  ·  Apr 30, 2026 READ →
TSLA
Volkswagen Q1 Earnings Call Highlights
Volkswagen (ETR:VOW3) executives used the company’s first-quarter 2026 results call to highlight a strong cash flow performance, continued weakness in the U.S. and China, and a “step-up and acceleration” of a transformation plan that management said is necessary to lift profitability in a tougher op
MarketBeat  ·  Apr 30, 2026 READ →
AAPL
Volkswagen Q1 Earnings Call Highlights
Volkswagen (ETR:VOW3) executives used the company’s first-quarter 2026 results call to highlight a strong cash flow performance, continued weakness in the U.S. and China, and a “step-up and acceleration” of a transformation plan that management said is necessary to lift profitability in a tougher op
MarketBeat  ·  Apr 30, 2026 READ →
TSLA
Elon Musk to return to witness stand for cross-examination by OpenAI's lawyer
By Deepa Seetharaman and Kenrick Cai OAKLAND, California, April 30 (Reuters) - Elon Musk is due to return to the witness stand on Thursday for a second day of cross-examination by Sam Altman's lawyer,
Reuters  ·  Apr 30, 2026 READ →
TSLA
‘Not all will survive’: Chinese EV giant delivers reality check to America. Is your portfolio in a dangerous position?
Competitors have been shaking in their boots at China’s pricing and efficiency.
Moneywise  ·  Apr 30, 2026 READ →
ETHUSDT
This Cryptocurrency Could Skyrocket 2,500%, According to a Top Wall Street Strategist
Can a cryptocurrency that's down 50% over the past eight months suddenly turn things around and hit a new all-time high?
Motley Fool  ·  Apr 30, 2026 READ →
MSFT
Google Cloud pulls ahead as Big Tech's AI bet swells to $700 billion
Alphabet's blowout cloud growth has reset expectations across major tech companies, leaving investors to recalibrate which firms are delivering the clearest returns. Alphabet shares jumped more than 6% in premarket trading on Thursday, while Meta stock fell ‌nearly 9%. Amazon shares rose 2.6%, while those of Microsoft dipped 1.8%.
Reuters  ·  Apr 30, 2026 READ →
GOOGL
Google Cloud pulls ahead as Big Tech's AI bet swells to $700 billion
Alphabet's blowout cloud growth has reset expectations across major tech companies, leaving investors to recalibrate which firms are delivering the clearest returns. Alphabet shares jumped more than 6% in premarket trading on Thursday, while Meta stock fell ‌nearly 9%. Amazon shares rose 2.6%, while those of Microsoft dipped 1.8%.
Reuters  ·  Apr 30, 2026 READ →
AMZN
Google Cloud pulls ahead as Big Tech's AI bet swells to $700 billion
Alphabet's blowout cloud growth has reset expectations across major tech companies, leaving investors to recalibrate which firms are delivering the clearest returns. Alphabet shares jumped more than 6% in premarket trading on Thursday, while Meta stock fell ‌nearly 9%. Amazon shares rose 2.6%, while those of Microsoft dipped 1.8%.
Reuters  ·  Apr 30, 2026 READ →
ETHUSDT
Ethereum Price Undervalued? Bullish Predictions Surge as Analysts Forecast 6 Million Daily Transactions by Year-End
AKS Ethereum network activity is surging, with daily transactions hitting a record 3.63 million. ETH may be undervalued despite stubborn prices. CCN analysts said key ...
CCN  ·  Apr 30, 2026 READ →
GS
Best CD rates today, April 30, 2026 (lock in up to 4.05% APY)
If you're on the hunt for today's best CD rates, we've narrowed down some of the top offers. Learn more about CD rates today, April 30, 2026, and how to open an account.
Yahoo Personal Finance  ·  Apr 30, 2026 READ →
HOOD
Johnson & Johnson (JNJ) Highlights Sustained Efficacy in Vivacity-MG3 Trial
We recently compiled a list of the 10 Most Popular Stocks on Robinhood in 2026. Johnson & Johnson is one of the most popular stocks on Robinhood. TheFly reported on April 22 that JNJ released updated findings from its Phase 3 Vivacity-MG3 trial and ongoing extension study evaluating IMAAVY (nipocalimab-aahu) in adults with generalized myasthenia […]
Insider Monkey  ·  Apr 30, 2026 READ →